Area of research
Immunology · Dermatology
Research interest
Research interests include Medicine, Internal medicine, Secukinumab, Clinical endpoint, Psoriasis Area and Severity Index, and Placebo.
An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote
Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab